Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Crinetics Pharmaceuticals Inc buy Jonestrading

Start price
€39.80
20.03.24 / 50%
Target price
€51.62
20.03.25
Performance (%)
-22.11%
End price
€31.00
21.03.25
Summary
This prediction ended on 21.03.25 with a price of €31.00. The prediction for Crinetics Pharmaceuticals Inc disappointed with a performance of -22.11%. Jonestrading has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Crinetics Pharmaceuticals Inc 5.392% 5.392% -19.626%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Jonestrading for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) -22.11%
Target price 51.621
Change
Ends at 20.03.25

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Jonestrading from $52.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for CRNX provided by MarketBeat

In the thread Trading Crinetics Pharmaceuticals Inc
Prediction Buy
Perf. (%) -22.11%
Target price 51.621
Change
Ends at 20.03.25

Die von Jonestrading gewählte maximale Laufzeit wurde überschritten